Skip to main content
Signal8

Liminatus Pharma Enters Into Warrant Exercise Transaction for $1.9 Million in Gross Proceeds

$LIMNPress releaseJun 3, 2026, 8:30 AM ETRead the release

Liminatus Pharma raised $1.9 million in gross proceeds by inducing existing warrant holders to exercise 10.34 million warrants at a reduced strike price of $0.18. In exchange, the company issued 20.688 million new unregistered warrants, also with a $0.18 strike price, effectively doubling the potential share count associated with this transaction.

Key figures

Deal Value Usd
1900000
Offering Price
0.18
Shares Offered
10344000
New warrant strike
0.18
New warrants issued
20688000
Warrant exercise price reduced to
0.18

AI analysis

Red flags4 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.